Hawaii Cannabis logo

By Allen St. Pierre, NORML Executive Director We read with interest the recent review of medical use of cannabinoids (1). As the authors attempt to emphasize, they focus on a heterogeneous collection of experiments that employed a range of treatments, including synthetic THC, CBD, and THC-mimicking drugs. Lay readers might inappropriately generalize these results